The use of low-dose il-2 for the treatment of autoimmune-related disorder or an inflammatory disorder
2012
The present invention relates to novel therapeutic methods for treating autoimmune and inflammatory diseases. More particularly, the present invention relates to the use of interleukin-2 in low doses for the treatment of type I diabetes and other autoimmune and / or inflammatory diseases.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI